We came across a bullish thesis on Compass Therapeutics, Inc. on r/stocks by  Cute_Confidence6033. In this article, we will summarize the bulls’ thesis on CMPX. Compass Therapeutics, Inc.'s share was trading at $5.70 as of January 16th. Taysha Gene Therapies Inc. (TSHA) is ‘Market Perform’ on Rett Syndrome Therapy: JMP Securities Compass Therapeutics (CMPX) is a clinical-stage oncology company with a focused pipeline targeting large, underserved cancer markets, and its current valuation appears disconnec ...